Viewing StudyNCT02942290



Ignite Creation Date: 2024-05-06 @ 9:17 AM
Last Modification Date: 2024-10-26 @ 12:12 PM
Study NCT ID: NCT02942290
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-05
First Post: 2016-10-18

Brief Title: A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes MDS
Sponsor: AbbVie
Organization: AbbVie

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes MDS
Keywords:
Name View
Higher-Risk HR Myelodysplastic Syndromes MDS View
Pharmacokinetic View
Venetoclax View
Azacitidine View
Acute Myelogenous Leukemia View
Myelodysplastic Syndromes MDS View
Treatment-Naïve Higher-Risk View